Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Rosenberg

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Endocrinology|December 20, 2011
Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individualsEunkyung Kauh, Lori Mixson, Marie-Pierre Malice, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 15, 2013
BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronateBrian Louis McNabb, Eric Vittinghoff, Ann V Schwartz, et al.
International Journal of Molecular Imaging|August 13, 2013
The Influence of Hypoxia and pH on Bioluminescence Imaging of Luciferase-Transfected Tumor Cells and XenograftsAshraf A Khalil, Mark J Jameson, William C Broaddus, et al.
Pain|December 28, 2010
Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic painDavid J Hewitt, Tony W Ho, Bradley Galer, et al.
Aging|June 14, 2011
Mutations in the BRCT binding site of BRCA1 result in hyper-recombinationSeth M Dever, Sarah E Golding, Elizabeth Rosenberg, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2015
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary DiseaseStephen I Rennard, David C Dale, James F Donohue, et al.
Biochimica Et Biophysica Acta|May 22, 2002
Members of the C/EBP transcription factor family stimulate expression of the human and rat surfactant protein A (SP-A) genesElizabeth Rosenberg, Feng Li, Samuel R Reisher, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2014
Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strengthAngela M Cheung, Sharmila Majumdar, Kim Brixen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 11, 2012
Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 studyBente Langdahl, Neil Binkley, Henry Bone, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2013
Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trialKim Brixen, Roland Chapurlat, Angela M Cheung, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Endocrinology|December 20, 2011
Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individualsEunkyung Kauh, Lori Mixson, Marie-Pierre Malice, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 15, 2013
BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronateBrian Louis McNabb, Eric Vittinghoff, Ann V Schwartz, et al.
International Journal of Molecular Imaging|August 13, 2013
The Influence of Hypoxia and pH on Bioluminescence Imaging of Luciferase-Transfected Tumor Cells and XenograftsAshraf A Khalil, Mark J Jameson, William C Broaddus, et al.
Pain|December 28, 2010
Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic painDavid J Hewitt, Tony W Ho, Bradley Galer, et al.
Aging|June 14, 2011
Mutations in the BRCT binding site of BRCA1 result in hyper-recombinationSeth M Dever, Sarah E Golding, Elizabeth Rosenberg, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2015
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary DiseaseStephen I Rennard, David C Dale, James F Donohue, et al.
Biochimica Et Biophysica Acta|May 22, 2002
Members of the C/EBP transcription factor family stimulate expression of the human and rat surfactant protein A (SP-A) genesElizabeth Rosenberg, Feng Li, Samuel R Reisher, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2014
Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strengthAngela M Cheung, Sharmila Majumdar, Kim Brixen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 11, 2012
Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 studyBente Langdahl, Neil Binkley, Henry Bone, et al.
The Journal of Clinical Endocrinology and Metabolism|January 23, 2013
Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trialKim Brixen, Roland Chapurlat, Angela M Cheung, et al.
Pageof 5